 |
|
Genentech, Inc. is a biotechnology
company that discovers, develops, manufactures and commercializes
biotherapeutics for significant unmet medical needs. Sixteen of
the approved biotechnology products originated from or are based
on Genentech science. The Company manufactures and commercializes
11 biotechnology products in the United States.
|
|
Number of Employees
|
5,252
|
Fiscal Year Ending Date
|
12/31/02
|
|
Sales (in millions)
|
$2,719.25
|
1-Yr. Sales Change
|
22.92%
|
|
|
Stock Data
|
|
Market Capitalization (in millions)
|
43,828.38
|
Percent Owned by Institutions
|
37.29%
|
|
Shares Outstanding (in millions)
|
523.20
|
Number of Institutional
Shareholders
|
1,179
|
|
Public Float (in millions)*
|
204.50
|
Percent Owned by Insiders
|
60.91%
|
|
Latest Dividend
|
n.a.
|
Last Stock Split
|
2 for 1
|
|
Date of Last Dividend
|
n.a.
|
Date of Last Split
|
10/25/00
|
|
Dividend Yield
|
n.a.
|
P/E Ratio
(without extraordinary items)
|
76.16
|
| |
P/E Ratio
(with extraordinary items)
|
82.94
|
|
|
*Shares outstanding, minus shares
controlled by insiders, restricted stock and shares held by 5%
owners
|
|
Short Interest
|
|
Total for current month
|
8,816,000
|
Short Interest Ratio**
|
2.81
|
|
Total for previous month
|
10,428,000
|
Short Interest as % of Public Float
|
4.31
|
|
|